UB Paderborn / Katalog / Suche / in CDI

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts

Journal of cardiovascular translational research, 2019-04, Vol.12 (2), p.116-123

2019

Volltextzugriff (PDF)

Mode-of-action of the PROPELLA concept in fulminant myocarditis

European heart journal, 2019-07, Vol.40 (26), p.2164-2169

2019

Volltextzugriff (PDF)

2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents

Journal of the American College of Cardiology, 2017-01, Vol.69 (2), p.162-171

2017

Volltextzugriff (PDF)

Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries

Therapeutic advances in cardiovascular disease, 2019-01, Vol.13, p.1753944719826335-1753944719826335

2019

Volltextzugriff (PDF)

Endpoint selection for noninferiority percutaneous coronary intervention trials: a methodological description

Therapeutic Advances in Cardiovascular Disease, 2020, Vol.14, p.1753944720911329

2020

Volltextzugriff (PDF)

TCT-549 The “Me & My Heart” (eMocial) Study: A Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of ACS patients

Journal of the American College of Cardiology, 2019-10, Vol.74 (13), p.B542-B542

2019

Volltextzugriff (PDF)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock

Open heart, 2019-05, Vol.6 (1), p.e000987-e000987

2019

Volltextzugriff (PDF)

Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels

Journal of interventional cardiology, 2019, Vol.2019, p.6548696-8

2019

Volltextzugriff (PDF)

Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial

Clinical research in cardiology, 2021-02, Vol.110 (2), p.162-171

2021

Volltextzugriff (PDF)

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy

Human molecular genetics, 2008-09, Vol.17 (18), p.2753-2765

2008

Volltextzugriff (PDF)

TCT-553 Percutaneous hemodynamic support in patients with cardiogenic shock due to acute myocardial infarction

Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.B229-B229

2017

Volltextzugriff (PDF)

Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Cardiovascular drugs and therapy, 2020-06, Vol.34 (3), p.335-344

2020

Volltextzugriff (PDF)

Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2

Clinical cardiology (Mahwah, N.J.), 2018-05, Vol.41 (5), p.569-575

2018

Volltextzugriff (PDF)

The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports

BMC cardiovascular disorders, 2018-07, Vol.18 (1), p.155-155, Article 155

2018

Volltextzugriff (PDF)

TCT-727 Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture

Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.B309-B309

2017

Volltextzugriff (PDF)

TCT-731 Nine-month clinical outcomes in patients with diabetes treated with polymer free sirolimus-eluting stents and dual-anti platelet therapy (DAPT) for 6 months versus DAPT for 12 months

Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.B310-B311

2017

Volltextzugriff (PDF)

Valve embolization during transcatheter aortic valve implantation: Incidence, risk factors and follow-up by computed tomography

Frontiers in cardiovascular medicine, 2022-07, Vol.9, p.928740-928740

2022

Volltextzugriff (PDF)

TCT-867 Polymer-free sirolimus-eluting stents in an elderly and octogenarian all-comer population

Journal of the American College of Cardiology, 2018-09, Vol.72 (13), p.B345-B346

2018

Volltextzugriff (PDF)

TCT-728 Polymer-free sirolimus eluting stents in a large scale all comers population

Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.B97-B97

2017

Volltextzugriff (PDF)

Porcine arteriogenesis based on vasa vasorum in a novel semi-acute occlusion model using high-resolution imaging

Heart and vessels, 2017-11, Vol.32 (11), p.1400-1409

2017

Volltextzugriff (PDF)

Efficacy and Safety of Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents for Chronic Total Occlusions: Insights from the Coroflex ISAR 2000 Worldwide Registry

Cardiology research and practice, 2018-01, Vol.2018, p.8053168-7

2018

Volltextzugriff (PDF)

Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial

The American heart journal, 2023-04, Vol.258, p.77-84

2023

Volltextzugriff (PDF)

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

The Lancet (British edition), 2018-09, Vol.392 (10151), p.940-949

2018

Volltextzugriff (PDF)

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

The Lancet (British edition), 2018-09, Vol.392 (10150), p.849-856

2018

Volltextzugriff (PDF)

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease

The New England journal of medicine, 2016-12, Vol.375 (26), p.2603

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts

Mode-of-action of the PROPELLA concept in fulminant myocarditis

2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents

Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries

Endpoint selection for noninferiority percutaneous coronary intervention trials: a methodological description

TCT-549 The “Me & My Heart” (eMocial) Study: A Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of ACS patients

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock

Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels

Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy

TCT-553 Percutaneous hemodynamic support in patients with cardiogenic shock due to acute myocardial infarction

Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2

The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports

TCT-727 Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture

TCT-731 Nine-month clinical outcomes in patients with diabetes treated with polymer free sirolimus-eluting stents and dual-anti platelet therapy (DAPT) for 6 months versus DAPT for 12 months

Valve embolization during transcatheter aortic valve implantation: Incidence, risk factors and follow-up by computed tomography

TCT-867 Polymer-free sirolimus-eluting stents in an elderly and octogenarian all-comer population

TCT-728 Polymer-free sirolimus eluting stents in a large scale all comers population

Porcine arteriogenesis based on vasa vasorum in a novel semi-acute occlusion model using high-resolution imaging

Efficacy and Safety of Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents for Chronic Total Occlusions: Insights from the Coroflex ISAR 2000 Worldwide Registry

Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease

Suchergebnisse filtern